Cucurbitacin B interacts synergistically with antibiotics against Staphylococcus aureus clinical isolates and exhibits antiviral activity against HSV-1.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F17%3A43875735" target="_blank" >RIV/62157124:16370/17:43875735 - isvavai.cz</a>
Alternative codes found
RIV/60460709:41330/17:71041
Result on the web
<a href="http://dx.doi.org/10.1016/j.sajb.2016.10.001" target="_blank" >http://dx.doi.org/10.1016/j.sajb.2016.10.001</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.sajb.2016.10.001" target="_blank" >10.1016/j.sajb.2016.10.001</a>
Alternative languages
Result language
angličtina
Original language name
Cucurbitacin B interacts synergistically with antibiotics against Staphylococcus aureus clinical isolates and exhibits antiviral activity against HSV-1.
Original language description
The search for biologically promising compounds from natural sources against microbial diseases remains an important theme in drug discovery to overcome problems with drug-resistant strains. In this study, Cucurbitacin B (Cuc B), an active constituent of Ecballium elaterium L., has been investigated in vitro for its synergy effect with antibiotics against clinical isolates of Staphylococcus aureus (S. aureus) and anti-HSV-1 activity. Broth microdilution method was used to determine the antibacterial activity, while checkerboard assay was used to evaluate the synergy effect according to ?FIC indices. The anti-HSV-1 activity was determined by the plaque number reduction assay, while cytotoxicity was evaluated by MTT assay. In this study, Cuc B exerted direct growth-inhibitory activity against all S. aureus strains tested with MICs values ranging from 0.12 to 0.44 ?g/mL, as well as synergy effect with tetracycline or oxacillin against four of six S. aureus strains tested (?FIC ranging from 0.29 to 0.43). Cuc B showed remarkable anti-HSV-1 activity compared with that of acyclovir with IC50 values of 0.94 and 1.74 ?M, respectively and selectivity indices SI = 127.7 and SI N 132.2, respectively. This study presents Cuc B as a promising therapeutic agent in the development of anti-staphylococcal and anti-HSV-1 drugs.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
South African Journal of Botany
ISSN
0254-6299
e-ISSN
—
Volume of the periodical
108
Issue of the periodical within the volume
JAN 2017
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
5
Pages from-to
90-94
UT code for WoS article
000390671400009
EID of the result in the Scopus database
—